Gerd Schubert
Inventor
Stats
- 17 US patents issued
- 20 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 17 US Patents Issued
- 20 US Applications Filed
- 154 Total Citation Count
- Apr 12, 2007 Most Recent Filing
- Aug 14, 1985 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| Vegla Vereinigte Glaswerke GmbH | 1
| 1985
|
| Vegla | 1
| 1985
|
| BAYER SCHERING PHARMA AKTIENGESELLSCHAFT | 1
2 1 1 3 1 | 2000
2002 2003 2004 2006 2007 |
| SCHERING AKTIENGESELLSCHAFT | 1
2 1 1 2 4 | 1993
1994 1995 2000 2002 2003 |
| BAYER INTELLECTUAL PROPERTY GMBH | 1
3 5 | 2000
2001 2003 |
| HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2
| 2003
|
Inventor Addresses
| Address | Duration |
|---|---|
| Berlin, DE | Dec 08, 09 - Dec 08, 09 |
| Dena, DE | Apr 01, 04 - Apr 01, 04 |
| Herzogenrath, DE | Oct 28, 86 - Oct 28, 86 |
| Jena, DE | Apr 18, 95 - Jun 23, 09 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 16 |
| C03B: | MANUFACTURE OR SHAPING OF GLASS, OR OF MINERAL OR SLAG WOOL; SUPPLEMENTARY PROCESSES IN THE MANUFACTURE OR SHAPING OF GLASS, OR OF MINERAL OR SLAG WOOL | 1 |
| C07C: | ACYCLIC OR CARBOCYCLIC COMPOUNDS | 3 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 7629334 | 2009 | Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT) | 0 |
| 7550451 | 2009 | Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy | 9 |
| 7473709 | 2009 | 11β-benzaldoxime derivatives of D-homooestra-4,9-dien-3-ones | 0 |
| 2007/0249,573 | 2007 | 17alpha-substituted 4-(3-oxoestra-4,9-dien-11beta-yl)-benzoic acid, its derivatives and process for its production | 0 |
| 7268241 | 2007 | Method for the production of 4-(17$g(a)-methyl substituted 3-oxoestra-4 9-dien-11$g(b)-yl)benzaldehyd-(1e or 1z)-oximes | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.